About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

TOWA PHARMACEUTICAL CO.,LTD.(4553) Summary

4553
TSE Prime
TOWA PHARMACEUTICAL CO.,LTD.
2,367
JPY
-91
(-3.70%)
Apr 9, 3:30 pm JST
16.28
USD
Apr 9, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
7.7
PBR
0.69
Yield
2.96%
Margin Trading Ratio
4.96
Stock Price
Apr 9, 2025
Opening Apr 9, 9:00 am
2,408 JPY 16.51 USD
Previous Close Apr 8
2,458 JPY 16.66 USD
High Apr 9, 9:01 am
2,417 JPY 16.57 USD
Low Apr 9, 2:02 pm
2,355 JPY 16.25 USD
Volume
120,900
Trading Value
0.29B JPY 1.98M USD
VWAP
2377.8 JPY 16.36 USD
Minimum Trading Value
236,700 JPY 1,628 USD
Market Cap
0.12T JPY 0.84B USD
Number of Trades
621
Liquidity & Number of Trades
As of Apr 9, 2025
Liquidity
Slightly High
1-Year Average
436
1-Year High Mar 7, 2025
1,946
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 4, 2025 4,500 203,800 45.29
Mar 28, 2025 5,900 202,100 34.25
Mar 21, 2025 5,300 192,000 36.23
Mar 14, 2025 6,000 209,400 34.90
Mar 7, 2025 5,700 190,600 33.44
Company Profile
TOWA PHARMACEUTICAL CO.,LTD. is a leading generic drug manufacturer with strengths in cardiovascular products. The company has expanded from serving clinics to pharmacies and has also entered the healthcare business.
Sector
Pharmaceuticals
TOWA PHARMACEUTICAL CO.,LTD. specializes in the manufacture and sale of prescription drugs, ranking among the top domestic producers of generic medicines, its main product line. The company directly sells its self-manufactured pharmaceuticals to medical institutions, as well as to distributors, pharmaceutical wholesalers, and other manufacturers. Through its group companies, TOWA is also involved in active pharmaceutical ingredient research and production, soft capsule manufacturing, and the planning, development, and contract manufacturing of health foods. Internationally, the company operates generic drug businesses in Europe and the United States through its holding company. Its group companies have research, development, and manufacturing bases in Europe, where they conduct generic drug sales and contract research, development, and manufacturing services.